verve-201

·Code: VERVE-201

verve-201: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (1)

Clinical Trials (1)

A Phase 1b Single Ascending Dose Study to Evaluate the Safety of VERVE-201 in Patients With Refractory Hyperlipidemia

NCT06451770·Phase 1·VERV
Recruiting

Frequently asked questions

Who is developing verve-201?

verve-201 is being developed by Verve Therapeutics, Inc..

How many clinical trials involve verve-201?

BioSniper tracks 1 clinical trial involving verve-201.

Get deeper analysis on verve-201

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    verve-201 — Drug Pipeline, Trials & FDA Status | BioSniper